Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed

Filed Under: Industry Tagged With: , , , , ,

AGC Inc. (TYO:5201) recently announced that it intends to launch a tender offer for the acquisition of MolMed S.p.A., an…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More
AGC Plans to Invest Over 200B Yen in CDMO Operations for…
AGC in Race to Bolster CDMO Operations Across US, Europe and Japan
AGC in Race to Bolster CDMO Operations Across US, Europe and…
Evonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine
Evonik Plans Further Investment in mRNA Field to Expand…
Mitsui Chemicals, Mitsui & Co Make Takeover Bid for Honshu Chemical
Mitsui Chemicals, Mitsui & Co Make Takeover Bid for…
Overview of Major M&A Projects Under Japanese Chemical Companies in 2020
Overview of Major M&A Projects Under Japanese Chemical…
AGC Set to Integrate Chlor-Alkali Subsidiaries in Southeast Asia
AGC Set to Integrate Chlor-Alkali Subsidiaries in Southeast…